Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| IRD_IRB_2014_01_002 | Other Identifier | IRD IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients may feel significant pain at the surgery site after they wake up from the surgery. Usually pain is managed in the ward by giving strong pain medication that may slow down your mobilization and recovery process. Some recent work in other countries has shown that if investigator give patients an injection at the end of the operation, patients have less need for pain medication when they wake up. If investigator find that is also true in our population, then we can use this method as routine step after this operation to improve pain management and early mobilization of our patients
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Bupivacaine infiltration | Experimental | 10 ml of 0.25 % Bupivacaine |
|
| Normal saline infiltration | Placebo Comparator | 10 ml of normal saline |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bupivacaine | Drug | 23 G spinal needle will be introduced along the nephrostomy tube for peri-tubal infiltration of 10 ml of 0.25 % Bupivacaine into renal capsule to skin. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean time for first demand of rescue analgesic | Mean time for first demand defined as the difference in time between the first time rescue medications is given to patient in post-operatively and the time the infiltration took place intra-operatively | Release of the patient from the hospital or 24 hours (whichever comes first) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Spinal Disc Prolapse
Any previous renal surgery
Complication secondary to PCNL
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Zeeshan Arshad, MBBS | Contact | zeeshandaa@hotmail.com | ||
| Naila Baig-Ansari, PhD | Contact | naila.baig.ansari@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Zeeshan Arshad, MBBS | The Indus Hospital | Principal Investigator |
| Zafar Zaidi, MBBS | The Indus Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Indus Hospital | Recruiting | Karachi | Sindh | Pakistan |
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| D000077330 | Saline Solution |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Normal saline infiltration | Other | 23 G spinal needle will be introduced along the nephrostomy tube for peri-tubal infiltration of 10 ml of normal saline into renal capsule to skin |
|
|
| D000588 |
| Amines |
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |